Home / People / James Parkes
James Parkes

James Parkes


CMS Cameron McKenna Nabarro Olswang LLP
Cannon Place
78 Cannon Street
United Kingdom
Languages English

James Parkes is a partner in the Corporate Team. He advises clients across a number of industry sectors on a wide range of transactions, including domestic and international mergers and acquisitions (both public and private), corporate finance transactions, joint ventures and corporate restructurings.

He specialises in advising issuers and investment banks on acquisitions, disposals, fundraisings and other transactions undertaken by companies admitted to the London Stock Exchange (both Main Market and AIM).

James is recognised as a leading practitioner by Chambers and Partners and Legal 500.

more less

“A star of the future… James is very calm under pressure and very to the point”

Chambers & Partners

Relevant experience

  • Galliford Try on its GBP 1.075 bn sale of its Linden Homes and Partnerships & Regeneration businesses to Bovis Homes
  • Mayfair Equity Partners on its GBP 79m recommended all-cash offer for Nasstar plc, by way of scheme of arrangement
  • LondonMetric Property on its GBP 415m recommended takeover of A&J Mucklow.
  • Strix on its GBP 190m AIM IPO.
  • Hollywood Bowl on its GBP 240m Main Market IPO.
  • Liberum on the GBP 73m AIM IPO of Aquis Exchange.
  • Summit Therapeutics on its USD 50m private placement and equity placing and associated Takeover Code ‘whitewash.
  • Big Yellow on its ABB placing to raise GBP 67m.
  • Galliford Try on its GBP 157m ‘cash-box’ rights issue.
  • RBS on its GBP 53m public company acquisition of FreeAgent by way of scheme of arrangement.
  • The management of Harvey Nash in relation to its GBP 98m acquisition by The Power of Talent.
  • The All England Lawn Tennis Ground on its Centre Court Debenture Issue 2016 – 2020, No. 1 Court Debenture Issue 2017 – 2021, Centre Court Debenture Issue 2021 – 2025, and GBP £65m acquisition of The Wimbledon Park Golf Club by way of scheme of arrangement.
  • Holtzbrinck Publishing on its merger of the majority of its Macmillan Science and Education business with Springer Science + Business Media.
  • CooperSurgical on its GBP 140m acquisition of the Wallace line of IVF products from Smiths Medical.
  • Finsbury Food on its GBP 20m acquisition of Ultrapharm, and its GBP 56m acquisition of Fletchers Bakeries.
more less


  • 2000 - LPC (Distinction), College of Law, London
  • 1999 - BA Law & History (Joint Hons), University College London, London
more less


Show only
23 April 2020
CMS tops UK ECM trans­ac­tions leg­al ad­viser rank­ings
CMS has ad­vised on five sep­ar­ate pla­cings for lis­ted com­pan­ies in the past week, re­in­for­cing the firm’s po­s­i­tion as the joint most act­ive leg­al ad­viser on ECM trans­ac­tions in Q1 2020 ac­cord­ing to ECM...
03 April 2020
Pre-Emption Group pub­lishes ex­pect­a­tions for is­su­ances in the cir­cum­stances...
On 1 April 2020, the Fin­an­cial Re­port­ing Coun­cil pub­lished a state­ment on be­half of the Pre-Emption Group (PEG) set­ting-out the PEG’s ex­pect­a­tions for is­su­ances dur­ing the eco­nom­ic tur­bu­lence caused...
01 April 2020
Guid­ance on Tem­por­ary Meas­ures for AGMs – an up­date for UK pub­lic com­pan­ies
Fur­ther to the UK Gov­ern­ment’s en­act­ment of le­gis­la­tion on 23 March 2020 re­quir­ing all non-key per­son­nel to “stay at home” (the “Stay At Home Meas­ures”), The Chartered Gov­ernance In­sti­tute...
26 March 2020
Ex­ten­sions to dead­lines for pub­lish­ing and fil­ing an­nu­al ac­counts and ad­di­tion­al...
In a com­bined ap­proach, the FCA, Lon­don Stock Ex­change and Com­pan­ies House have an­nounced a series of meas­ures ex­tend­ing the dead­lines for both the pub­lic­a­tion of fin­an­cial res­ults by lis­ted com­pan­ies...
23 March 2020
Tem­por­ary Coronavir­us Meas­ures for AIM com­pan­ies and Nomads
Cor­rect as of 10 am 23 March 2020. This art­icle is not be­ing main­tained. We pre­vi­ously pub­lished a Law-Now high­light­ing some of the po­ten­tial con­sequences of the spread of Coronavir­us for UK pub­lic com­pan­ies...
16 March 2020
AGMs in the time of Coronavir­us -con­sid­er­a­tions for UK pub­lic com­pan­ies
While it is dif­fi­cult to an­ti­cip­ate the prac­tic­al ef­fects of the con­tin­ued spread of nov­el Coronavir­us (“COV­ID-19”) in the UK, the po­ten­tial for gov­ern­ment-man­dated re­stric­tions on travel or pub­lic...
11 March 2020
En­quiry Let­ters from the FCA - In­vest­ig­a­tions in­to Mar­ket An­nounce­ments...
The FCA has re­spons­ib­il­ity for mon­it­or­ing the ac­cur­acy and timeli­ness of pub­lic an­nounce­ments made by pub­lic com­pan­ies with shares ad­mit­ted to list­ing or trad­ing (on the Of­fi­cial List, AIM and the Spe­cial­ist...
11 November 2019
CMS ad­vises Gal­li­ford Try on £1.1bn house­build­ing com­bin­a­tion with Bovis...
In­ter­na­tion­al law firm CMS has ad­vised Brit­ish con­struc­tion and house-build­ing group, Gal­li­ford Try, in re­la­tion to its land­mark trans­ac­tion to com­bine its Linden Homes and Gal­li­ford Try Part­ner­ships...
16 July 2018
ECM Mar­ket Re­view June 2018
The CMS ECM Mar­ket Re­view is a sum­mary of re­cent events in some of the key sec­tors that we fo­cus on.It is now just over a year since the mer­ger which cre­ated CMS Camer­on McK­enna Nabarro Olswang and its...
20 March 2018
AIM Rule Amend­ments
Fol­low­ing its con­sulta­tion at the end of 2017, Lon­don Stock Ex­change (the Ex­change) has ad­op­ted new Aim Rules sub­stan­tially in the form pro­posed. The new rules take ef­fect from 30 March 2018 al­though...
21 December 2017
Dis­cip­lin­ary mat­ters and les­sons for AIM com­pan­ies
In 2017, Lon­don Stock Ex­change (the Ex­change) has is­sued one pub­lic cen­sure and three private cen­sures.  In ad­di­tion, the FCA fined an AIM com­pany for fail­ing to an­nounce in­side in­form­a­tion in a timely...
21 December 2017
Takeover Code amend­ments to in­crease tar­get and em­ploy­ee pro­tec­tions
Un­der changes to the Takeover Code that will take ef­fect on 8 Janu­ary 2018, a party mak­ing a takeover of­fer will have to provide more in­form­a­tion, and at an earli­er stage, about how the trans­ac­tion will...